Get the Stockscreener App
0.60
8.18%
0.017
Virpax Pharmaceuticals Inc Stock (VRPX) Forecast
The Virpax Pharmaceuticals Inc (VRPX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.4048, representing a +1,467% increase from the current price of $0.60. The highest analyst price target is $16.75, and the lowest is $2.0617.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VRPX Price Target
Average 8.4512
(+1,309% Upside)
Is Virpax Pharmaceuticals Inc (VRPX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.44 | Neutral |
| STOCH(9,6) | 42.32 | Neutral |
| STOCHRSI(14) | 30.53 | Neutral |
| MACD(12,26) | -0.00576 | Sell |
| ADX(14) | 16.10 | Neutral |
| William %R | -58.33 | Neutral |
| CCI(14) | -35.56 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6547
Sell
|
0.656
Sell
|
| MA20 |
0.6818
Sell
|
0.6614
Sell
|
| MA50 |
0.6556
Sell
|
0.7045
Sell
|
| MA100 |
0.8658
Sell
|
0.9611
Sell
|
| MA200 |
1.7094
Sell
|
1.998
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VRPX could be considered a Strong Sell, with 17 technical analysis indicators signaling 0 Buy signals, 11 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on VRPX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.44 indicates that VRPX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 42.32 indicates that VRPX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.53 indicates that VRPX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.1 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -35.56 indicates that VRPX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VRPX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Virpax Pharmaceuticals Inc financial reports and earnings history, Virpax Pharmaceuticals Inc (VRPX) stock could reach $3.236 by 2030, $9.7699 by 2040 and $17.99 by 2050. See the projected annual prices until 2050 of the Virpax Pharmaceuticals Inc stock below:
- Virpax Pharmaceuticals Inc (VRPX) is expected to reach an average price of $0.2629 in 2035, with a high prediction of $3.9885 and a low estimate of $0.7471. This indicates an $-56.18% rise from the last recorded price of $0.60.
- Virpax Pharmaceuticals Inc (VRPX) stock is projected to chart a bullish course in 2040, with an average price target of $9.8406, representing an $1,540% surge from its current level. The forecast ranges from a conservative $9.8503 to a sky-high $9.7699.
- Our analysts predict Virpax Pharmaceuticals Inc (VRPX) to jump 1,571% by 2045, soaring from $10.10 to an average price of $10.03, potentially reaching $10.25. While $10.10 is the low estimate, the potential upside is significant.
- Virpax Pharmaceuticals Inc (VRPX) stock is expected to climb by 2050, reaching an average of $18.15, a $2,925% jump from its current level. However, a wide range of estimates exists, with high and low targets of $17.99 and $18.24, respectively, highlighting the market's uncertainty.
Virpax Pharmaceuticals Inc Stock (VRPX) Year by Year Forecast
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2024
Our forecast for VRPX stock price in 2024 now indicates an average price target of $16.81 with a high forecast of $33.36 and a low forecast of $0.2543. The average prediction reflects an increase of +2,702% from the last recorded price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $2.1117 | $2.0617 | $16.75 | +251.96% |
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2025
Virpax Pharmaceuticals Inc Stock (VRPX) is expected to reach an average price of $1.6447 in 2025, with a high prediction of $3.1348 and a low estimate of $0.1545. This indicates an +174.11% rise from the last recorded price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.6914 | $1.4964 | $2.8897 | +181.90% |
| February, 2025 | $1.6231 | $1.2352 | $1.8731 | +170.52% |
| March, 2025 | $1.5648 | $0.9053 | $3.1348 | +160.81% |
| April, 2025 | $0.4245 | $0.3445 | $1.6328 | -29.25% |
| May, 2025 | $0.3038 | $0.2176 | $0.5824 | -49.37% |
| June, 2025 | $0.2121 | $0.2858 | $0.21 | -64.66% |
| July, 2025 | $0.1224 | $0.1724 | $0.1641 | -79.60% |
| August, 2025 | $0.5507 | $0.1545 | $0.2835 | -8.22% |
| September, 2025 | $0.9889 | $0.6248 | $0.8248 | +64.82% |
| October, 2025 | $0.8093 | $0.8631 | $0.811 | +34.88% |
| November, 2025 | $0.4276 | $0.5655 | $0.6514 | -28.74% |
| December, 2025 | $0.5479 | $0.6659 | $0.5738 | -8.68% |
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2026
The predicted value for Virpax Pharmaceuticals Inc (VRPX) in 2026 is set at an average of $1.0081. Estimates vary from a peak of $1.2505 to a trough of $0.7657, indicating an +68.01% surge from the present price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.9106 | $0.86 | $0.8462 | +51.76% |
| February, 2026 | $0.9145 | $0.9003 | $0.8246 | +52.41% |
| March, 2026 | $1.0427 | $0.9515 | $0.9627 | +73.79% |
| April, 2026 | $1.2231 | $1.0649 | $1.1532 | +103.85% |
| May, 2026 | $1.2213 | $1.2143 | $1.1614 | +103.56% |
| June, 2026 | $1.1396 | $1.2595 | $1.2505 | +89.94% |
| July, 2026 | $0.87 | $0.915 | $1.1317 | +44.99% |
| August, 2026 | $0.9682 | $0.892 | $0.9062 | +61.37% |
| September, 2026 | $1.0788 | $1.0803 | $1.0616 | +79.80% |
| October, 2026 | $1.1106 | $1.1427 | $1.0748 | +85.09% |
| November, 2026 | $1.0102 | $1.025 | $0.9651 | +68.37% |
| December, 2026 | $0.6755 | $0.7657 | $0.9872 | +12.58% |
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Virpax Pharmaceuticals Inc (VRPX) is $2.2578, with a high forecast of $4.0656 and a low forecast of $0.45. This indicates an +276.30% increase from the last price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.8287 | $0.7474 | $0.7469 | +38.12% |
| February, 2027 | $0.7819 | $0.8579 | $0.7958 | +30.32% |
| March, 2027 | $0.8634 | $0.8082 | $0.8025 | +43.89% |
| April, 2027 | $0.8004 | $0.8481 | $0.8065 | +33.41% |
| May, 2027 | $0.8679 | $0.8803 | $0.8426 | +44.65% |
| June, 2027 | $1.1541 | $0.8896 | $1.1493 | +92.34% |
| July, 2027 | $1.1974 | $1.2038 | $1.1463 | +99.57% |
| August, 2027 | $1.1757 | $1.1958 | $1.174 | +95.95% |
| September, 2027 | $1.1082 | $1.142 | $1.1479 | +84.69% |
| October, 2027 | $2.7546 | $1.1582 | $4.0656 | +359.10% |
| November, 2027 | $2.1673 | $1.8674 | $3.4185 | +261.22% |
| December, 2027 | $0.31 | $0.45 | $2.6652 | -48.33% |
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2028
In 2028, Virpax Pharmaceuticals Inc (VRPX) is projected to reach an average price of $15.52, with a high projection of $30.73 and a low estimate of $0.3176. This indicates an +2,487% rise from the last price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0965 | $0.4224 | $0.6877 | +82.76% |
| February, 2028 | $1.2531 | $0.9048 | $0.6148 | +108.85% |
| March, 2028 | $1.3438 | $1.5972 | $1.4596 | +123.96% |
| April, 2028 | $1.5603 | $1.0362 | $1.7838 | +160.06% |
| May, 2028 | $0.151 | $1.131 | $3.1231 | -74.83% |
| June, 2028 | $0.7576 | $0.8676 | $0.7107 | +26.26% |
| July, 2028 | $12.38 | $1.1517 | $30.73 | +1,963% |
| August, 2028 | $0.5948 | $0.3176 | $12.82 | -0.87% |
| September, 2028 | $0.8814 | $0.9189 | $0.7314 | +46.89% |
| October, 2028 | $0.5679 | $0.9955 | $0.8396 | -5.35% |
| November, 2028 | $1.1486 | $0.972 | $0.8786 | +91.43% |
| December, 2028 | $2.5751 | $1.8127 | $1.8551 | +329.19% |
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2029
The 2029 price forecast for Virpax Pharmaceuticals Inc Stock (VRPX) is $2.8376 on average, with a high prediction of $3.1862 and a low estimate of $2.4889. This represents an +372.93% increase from the previous price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6658 | $2.6917 | $2.6134 | +344.30% |
| February, 2029 | $2.6524 | $2.7041 | $2.60 | +342.06% |
| March, 2029 | $2.4589 | $2.4889 | $2.4266 | +309.82% |
| April, 2029 | $2.8355 | $2.6031 | $2.7056 | +372.58% |
| May, 2029 | $3.1062 | $2.9196 | $3.1038 | +417.69% |
| June, 2029 | $2.9527 | $3.0922 | $3.0403 | +392.12% |
| July, 2029 | $2.7693 | $2.781 | $2.711 | +361.54% |
| August, 2029 | $3.0199 | $2.8338 | $2.7575 | +403.32% |
| September, 2029 | $2.9965 | $3.0524 | $2.9824 | +399.42% |
| October, 2029 | $3.1072 | $3.0206 | $2.9773 | +417.86% |
| November, 2029 | $3.1337 | $3.1297 | $3.0396 | +422.29% |
| December, 2029 | $3.2103 | $3.2479 | $3.1862 | +435.05% |
Virpax Pharmaceuticals Inc Stock (VRPX) Price Forecast for 2030
Virpax Pharmaceuticals Inc Stock (VRPX) is expected to reach an average price of $2.8524 in 2030, with a high forecast of $3.236 and a low forecast of $2.4688. This signifies an +375.40% surge from the last price of $0.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.3487 | $3.2315 | $3.236 | +458.11% |
| February, 2030 | $3.1016 | $3.1592 | $3.1851 | +416.94% |
| March, 2030 | $2.6994 | $2.8141 | $2.8517 | +349.89% |
| April, 2030 | $2.8902 | $2.8628 | $2.8123 | +381.70% |
| May, 2030 | $2.9341 | $2.9689 | $2.9202 | +389.02% |
| June, 2030 | $2.7578 | $2.9321 | $2.9096 | +359.64% |
| July, 2030 | $2.6585 | $2.7785 | $2.7744 | +343.09% |
| August, 2030 | $2.4551 | $2.495 | $2.4427 | +309.18% |
| September, 2030 | $2.5416 | $2.5133 | $2.5116 | +323.61% |
| October, 2030 | $2.4923 | $2.5023 | $2.4858 | +315.39% |
| November, 2030 | $2.5189 | $2.4765 | $2.4548 | +319.81% |
| December, 2030 | $2.4806 | $2.4688 | $2.443 | +313.44% |
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):